98 related articles for article (PubMed ID: 10782550)
1. Changes in negative symptoms and the risk of tardive dyskinesia: a longitudinal study. UK700 Group.
van Os J; Walsh E; van Horn E; Tattan T; Bale R; Thompson SG
Acta Psychiatr Scand; 2000 Apr; 101(4):300-6. PubMed ID: 10782550
[TBL] [Abstract][Full Text] [Related]
2. Worsening of psychosis in schizophrenia is longitudinally associated with tardive dyskinesia in the European Schizophrenia Outpatient Health Outcomes study.
Tenback DE; van Harten PN; Slooff CJ; van Os J;
Compr Psychiatry; 2007; 48(5):436-40. PubMed ID: 17707251
[TBL] [Abstract][Full Text] [Related]
3. Focus on lower risk of tardive dyskinesia with atypical antipsychotics.
Nasrallah HA
Ann Clin Psychiatry; 2006; 18(1):57-62. PubMed ID: 16517454
[TBL] [Abstract][Full Text] [Related]
4. Ten year outcome of tardive dyskinesia during continuous treatment with first generation antipsychotics.
Rittmannsberger H
Psychiatr Danub; 2008 Dec; 20(4):461-5. PubMed ID: 19011586
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
Hansen TE; Brown WL; Weigel RM; Casey DE
J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762
[TBL] [Abstract][Full Text] [Related]
6. The natural history of tardive dyskinesia.
Gardos G; Cole JO; Haskell D; Marby D; Paine SS; Moore P
J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):31S-37S. PubMed ID: 2906068
[TBL] [Abstract][Full Text] [Related]
7. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
Glazer WM
J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326
[TBL] [Abstract][Full Text] [Related]
8. Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.
Akbostanci MC; Atbaşoğlu EC; Balaban H
Acta Neurol Belg; 1999 Sep; 99(3):176-81. PubMed ID: 10544725
[TBL] [Abstract][Full Text] [Related]
9. Case series: spectrum of neuroleptic-induced movement disorders and extrapyramidal side effects in childhood-onset schizophrenia.
Kumra S; Jacobsen LK; Lenane M; Smith A; Lee P; Malanga CJ; Karp BI; Hamburger S; Rapoport JL
J Am Acad Child Adolesc Psychiatry; 1998 Feb; 37(2):221-7. PubMed ID: 9473920
[TBL] [Abstract][Full Text] [Related]
10. Factors related to the severity of tardive dyskinesia.
Wade JB; Hart RP; Dougherty LM
Brain Cogn; 1993 Sep; 23(1):71-80. PubMed ID: 8105823
[TBL] [Abstract][Full Text] [Related]
11. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
[TBL] [Abstract][Full Text] [Related]
12. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
Honer WG; Kopala LC; Rabinowitz J
J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
[TBL] [Abstract][Full Text] [Related]
13. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications.
Glazer WM; Morgenstern H; Doucette JT
J Clin Psychiatry; 1993 Apr; 54(4):133-9. PubMed ID: 8098030
[TBL] [Abstract][Full Text] [Related]
14. Handedness and the risk of tardive dyskinesia.
Morgenstern H; Glazer WM; Doucette JT
Biol Psychiatry; 1996 Jul; 40(1):35-42. PubMed ID: 8780853
[TBL] [Abstract][Full Text] [Related]
15. Levetiracetam in tardive dyskinesia.
Meco G; Fabrizio E; Epifanio A; Morgante F; Valente M; Vanacore N; Di Rosa AE; Morgante L
Clin Neuropharmacol; 2006; 29(5):265-8. PubMed ID: 16960471
[TBL] [Abstract][Full Text] [Related]
16. Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia.
Damier P; Thobois S; Witjas T; Cuny E; Derost P; Raoul S; Mertens P; Peragut JC; Lemaire JJ; Burbaud P; Nguyen JM; Llorca PM; Rascol O;
Arch Gen Psychiatry; 2007 Feb; 64(2):170-6. PubMed ID: 17283284
[TBL] [Abstract][Full Text] [Related]
17. Tardive dyskinesia and impaired glucose tolerance.
Chong SA; Mythily ; Lum A; Huak CY; Kane J
Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
[TBL] [Abstract][Full Text] [Related]
18. Evidence that lithium protects against tardive dyskinesia: the Curaçao Extrapyramidal syndromes study VI.
van Harten PN; Hoek HW; Matroos GE; van Os J
Eur Neuropsychopharmacol; 2008 Feb; 18(2):152-5. PubMed ID: 17822885
[TBL] [Abstract][Full Text] [Related]
19. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
20. Tardive dyskinesia: determinants of temporal dynamics of its emergence.
Latalova K
Neuro Endocrinol Lett; 2008 Dec; 29(6):995-8. PubMed ID: 19112392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
